SCLX Stock Acquisition JV LLC - 03 Jul 2026 Form 4 Insider Report for Scilex Holding Co (SCLX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
07 Jul 2026, 21:25:20 UTC
Prior SEC filing
23 Jan 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Xiao Xu, Sole Manager

Key filing fact

SCLX Stock Acquisition JV LLC filed Form 4 for Scilex Holding Co (SCLX) on 07 Jul 2026.

Key facts

  • This page summarizes SCLX Stock Acquisition JV LLC's Form 4 filing for Scilex Holding Co (SCLX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 07 Jul 2026, 21:25.

Change

  • Previous filing in this sequence was filed on 23 Jan 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001994894 Primary reporting owner

SCLX Stock Acquisition JV LLC

Relationship
10%+ Owner
Address
C/O SCILEX HOLDING COMPANY, 960 SAN ANTONIO ROAD, PALO ALTO
Signature
/s/ Xiao Xu, Sole Manager
Signature date
06 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SCLX transaction

Common stock

Other

Transaction value
Shares
-500,000
Change %
-34%
Price
Shares after
958,263
Date
03 Jul 2026
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

On July 3, 2026, the Reporting Person entered into a letter agreement (the "Letter Agreement") with Quantum Scan Holdings, Inc. ("Q Scan") and the other party named therein, pursuant to which the Reporting Person transferred the shares reported herein to Q Scan in exchange for shares of common stock of Q Scan. The price at which the shares reported herein are being transferred to Q Scan will be based on the closing price of the shares of Scilex common stock on the Nasdaq Capital Market on the last trading day immediately prior to the transfer of such shares pursuant to the Letter Agreement.

Footnote F2

The number of shares beneficially owned reflects the 1-for-35 reverse stock split effected April 15, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .